Company intelligence / Profile preview

Reliev Technologies

Nantes or regionally nearby (inferred), Pays de la Loire (inferred from Atlanpole cluster location), Francereliev.io ↗

Ownership: Private
Development stage: Other

Overview

Reliev Technologies develops a medical device aimed at improving seizure observability for people with epilepsy, particularly those with drug-resistant forms. The technology focuses on providing real-time seizure monitoring to support patients, families, and neurologists in optimizing treatment adjustments. No published clinical results are available as of now.

Therapeutic areas: Neurology
Modalities: DeviceDigital health solution (seizure detection system)
Industry: Physiological Monitoring

Partnerships

Atlanpole (French innovation cluster/incubator)

Beyond the preview

Go deeper on Reliev Technologies.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Reliev Technologies.

Explore the full profile